Rachel B. Issaka's research while affiliated with Fred Hutch Cancer Center and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (67)
Colorectal cancer (CRC) is a common and preventable cancer. CRC screening is underutilized, particularly within medically underserved communities. Most interventions aimed at increasing CRC screening are delivered through primary care clinics. Pharmacies are more accessible than traditional primary care settings and may be ideally suited for delive...
Goals
We aimed to determine the performance of the OC-Auto Micro 80 fecal immunochemical test (FIT) in an average-risk population receiving care in an integrated, academic-community health system.
Background
The FIT is the most used colorectal cancer (CRC) screening test worldwide. However, many Food and Drug Administration–cleared FIT products ha...
Background
The United States Preventive Services Task Force (USPSTF) lists 32 grade A or B recommended preventive services for non-pregnant United States (US) adults, including colorectal cancer screening (CRC). Little guidance is given on how to implement these services with consistency and fidelity in primary care. Given limited patient visit tim...
HCC, the most common form of primary liver cancer, is the fastest rising cause of cancer-related death in the United States. HCC disproportionately affects racial and ethnic minorities in the United States. A practical framework is needed to organize the complex patient, provider, health system, and societal factors that drive these racial and ethn...
Introduction:
Surveillance colonoscopy 1-year after surgical resection for patients with stages I-III colorectal cancer (CRC) is suboptimal and data on factors associated with lack of adherence are limited. Using surveillance colonoscopy data from Washington state, we aimed to determine the patient, clinic, and geographical factors associated with...
Background
The United States Preventive Services Task Force (USPSTF) lists 32 grade A or B recommended preventive services for non-pregnant United States (US) adults, including colorectal cancer screening (CRC). Little guidance is given on how to implement these services with consistency and fidelity in primary care. Given limited patient visit tim...
Background & aims:
Structural racism and discrimination (SRD) are important upstream determinants of health perpetuated by discriminatory laws and policies. Therefore, measuring SRD and its impact on health is critical to developing interventions that address resultant health disparities. We aimed to identify gastrointestinal (GI) or liver studies...
Background and aims:
In the setting of increasing attention to representation in medicine, we aimed to assess current perspectives of racial and ethnic workforce diversity and health care disparities among gastroenterology (GI) and hepatology professionals in the United States.
Approach and results:
We developed and administered a 33-item electr...
Background & aims:
In the setting of increasing attention to representation in medicine, we aimed to assess current perspectives of racial and ethnic workforce diversity and health care disparities among gastroenterology (GI) and hepatology professionals in the United States.
Methods:
We developed and administered a 33-item electronic cross-sect...
Background & aims:
In the setting of increasing attention to representation in medicine, we aimed to assess current perspectives of racial and ethnic workforce diversity and health care disparities among gastroenterology (GI) and hepatology professionals in the United States.
Methods:
We developed and administered a 33-item electronic cross-sect...
Background aims:
In the setting of increasing attention to representation in medicine, we aimed to assess current perspectives of racial and ethnic workforce diversity and health care disparities among gastroenterology (GI) and hepatology professionals in the United States.
Methods:
We developed and administered a 33-item electronic cross-sectio...
In safety-net healthcare systems, colonoscopy completion within 1-year of an abnormal fecal immunochemical test (FIT) result rarely exceeds 50%. Understanding how electronic health records (EHR) documented reasons for missed colonoscopy match or differ from patient-reported reasons, is critical to optimize effective interventions to address this ch...
Background
Gender-based differences in the use of professional titles during speaker introductions have been described in other medical specialties.AimsOur primary aim was to assess gender-based differences in the formality of speaker introductions at the American College of Gastroenterology 2020 Virtual Annual Scientific Meeting. Our secondary aim...
Introduction
Transportation is a common barrier to colonoscopy completion for colorectal cancer (CRC) screening. The study aims to identify the barriers, facilitators, and process recommendations to implement a rideshare non-emergency medical transportation (NEMT) intervention following colonoscopy completion within a safety-net healthcare setting....
Importance
The effectiveness of stool-based colorectal cancer (CRC) screening, including fecal immunochemical tests (FITs), relies on colonoscopy completion among patients with abnormal results, but in safety net systems and federally qualified health centers, in which FIT is frequently used, colonoscopy completion within 1 year of an abnormal resu...
Introduction:
The initial surge of the coronavirus disease 2019 (COVID-19) pandemic prompted national recommendations to delay nonurgent endoscopic procedures. The objective of this study was to provide real-world data on the impact of COVID-19 on endoscopic procedures in a safety-net healthcare system and cancer center affiliated with a tertiary...
Importance
COVID-19 has decreased colorectal cancer screenings.
Objective
To estimate the degree to which expanding fecal immunochemical test–based colorectal cancer screening participation during the COVID-19 pandemic is associated with clinical outcomes.
Design, Setting, and Participants
A previously developed simulation model was adopted to es...
Background:
Evidence-based interventions (EBIs) could reduce cervical cancer deaths by 90%, colorectal cancer deaths by 70%, and lung cancer deaths by 95% if widely and effectively implemented in the USA. Yet, EBI implementation, when it occurs, is often suboptimal. This manuscript outlines the protocol for Optimizing Implementation in Cancer Cont...
Objective
Digital health care offers an opportunity to scale and personalize cancer screening programs, such as mailed outreach for colorectal cancer (CRC) screening. However, studies that describe the patient selection strategy and process for CRC screening are limited. Our objective was to evaluate implementation strategies for selecting patients...
Background
How clinical teams function varies across sites and may affect follow-up of abnormal fecal immunochemical test (FIT) results.AimsThis study aimed to identify the characteristics of clinical practices associated with higher diagnostic colonoscopy completion after an abnormal FIT result in a multi-site integrated safety-net system.Methods...
The NCCN Guidelines for Colorectal Cancer (CRC) Screening describe various colorectal screening modalities as well as recommended screening schedules for patients at average or increased risk of developing sporadic CRC. They are intended to aid physicians with clinical decision-making regarding CRC screening for patients without defined genetic syn...
Background:
Mailed fecal immunochemical test (FIT) outreach effectively increases colorectal cancer (CRC) screening but is underutilized. This pilot aimed to determine the use of FIT for CRC screening among Medicare Advantage enrollees when offered via mailed outreach and the factors associated with FIT return.
Methods:
Our pilot study included...
Background
Phone calls as part of multimodal fecal immunochemical test (FIT) outreach are effective but resource-intensive. Previous studies of advanced notification calls before FIT mailing have not differentiated patients’ prior screening status.Objective
To determine the effectiveness of a phone call preceding mailing of a FIT kit on test comple...
I began my second year of gastroenterology fellowship after logging hundreds of procedures, scoring high marks in peer and patient reviews, and developing a reputation as a strong endoscopist and clinician. I was proud of my progress but was even more thrilled to no longer carry the department’s on-call pager every other night. One day while roundi...
In response to the COVID-19 pandemic, the United States Surgeon General advised all hospitals and ambulatory care centers to delay nonurgent medical procedures and surgeries. This recommendation, echoed by a multigastroenterology society guideline, led to the suspension of colonoscopies for colorectal cancer (CRC) screening and surveillance. Althou...
Greater than the coronavirus disease 2019 (COVID-19) crisis, systemic inequity in social determinants of health is the pandemic that has long fostered vulnerability to disease and poor health outcomes in the USA. Our response has major implications for the health of our nations.
Uptake of colorectal cancer screening remains suboptimal. Mailed fecal immunochemical testing (FIT) offers promise for increasing screening rates, but optimal strategies for implementation have not been well synthesized. In June 2019, the Centers for Disease Control and Prevention convened a meeting of subject matter experts and stakeholders to ans...
Background. Surveillance colonoscopy 1-year after colorectal cancer (CRC) surgery effectively reduces CRC mortality, yet less than half of survivors undergo this procedure. Text message reminders can improve CRC screening and other health behaviors, but use of this strategy to address barriers to CRC surveillance has not been reported. Objectives....
Introduction
In Western Washington (WA), colorectal cancer (CRC) mortality between 2012 and 2016 was highest in American Indian/Alaska Natives (AI/AN) and African-Americans (AA) at 20.7 and 18.7, respectively, compared with non-Hispanic Whites at 14.1/100,000 people. We hypothesized that time from billed encounters for CRC-associated symptoms to en...
Adenovirus is an infrequent but challenging viral complication of transplantation that is rarely reported after autologous stem cell transplant. We present a case of disseminated adenovirus infection in a woman who received an autologous stem cell transplant for treatment of multiple sclerosis. After presenting with post‐transplant episodic diarrhe...
Screening reduces colorectal cancer mortality; however, this remains the second leading cause of cancer deaths in the United States and adherence to colorectal cancer screening falls far short of the National Colorectal Cancer Roundtable goal of 80%. Numerous studies have examined the effectiveness of interventions to increase colorectal cancer scr...
The identification of germline pathogenic/likely pathogenic (P/LP) variants in cancer predisposition genes can guide treatment and management decisions for the individual being tested and potentially at-risk relatives. Prior studies have raised concerns of racial/ethnic disparities in the detection rates of P/LP variants and variants of uncertain s...
Background:
Colorectal cancer (CRC) screening remains underutilized especially in safety-net systems. The objective of this study was to determine the effectiveness, costs, and cost-effectiveness of organized outreach using fecal immunochemical tests (FIT) compared with usual care.
Methods:
Patients aged 50-75 years eligible for CRC screening fr...
Background & aims:
The fecal immunochemical test (FIT) is an alternative to colonoscopy and can increase overall screening for colorectal cancer (CRC). However, little is known about the frequency of and reasons for mishandled FIT samples.
Methods:
We performed a prospective study, nested within a randomized controlled trial of patients, recruit...
Despite clear evidence that colorectal cancer (CRC) screening reduces mortality, screening, including fecal immunochemical tests (FIT), is underutilized. We conducted a systematic review to determine the evidence of efficacy of interventions to improve FIT completion that could be scaled and utilized in population health management. We systematical...
Background & aims:
The fecal immunochemical test (FIT) is widely used in colorectal cancer (CRC) screening. The OC-Light FIT is 1 of 2 FITs recommended for CRC screening by the Preventive Services Task Force guidelines. However, little is known about its ability to detect CRC in large average-risk populations.
Methods:
We performed a retrospecti...
Objectives:
The effectiveness of stool-based colorectal cancer (CRC) screening is contingent on colonoscopy completion in patients with an abnormal fecal immunochemical test (FIT). Understanding system and patient factors affecting follow-up of abnormal screening tests is essential to optimize care for high-risk cohorts.
Methods:
This retrospect...
Citations
... The study revealed that both age groups had a comparable occurrence of colon adenomas: 14% in the 40-49 age range and 16% in the 50-59 age range [33]. Recently published guidelines by the American Gastroenterological Association (AGA) recommend that individuals carrying mid-risk CRC probability should commence screening protocols at age 45, while individuals having exacerbated CRC risk due to first-degree relative/s developing CRC should commence screening protocols at least 10 years prior to age of CRC development within said relative, or commence screening at age 40 [34]. ...
... First, the response rate of 7.7% is low but is consistent with other studies distributed through large email contact lists without incentives for participation. [41,42] In addition, the representativeness of our sample size is limited by a lack of gender diversity, with no respondents reporting that they are nonbinary, as well as an overrepresentation of female and White respondents. Furthermore, several of our findings may be reflective of medical training more broadly and may not be unique to hepatology. ...
... A diverse medical and research workforce has been shown to drive innovation and improve access to high-quality, culturally competent patient-centered care for racial and ethnic minorities. 1,2 Further, diversity in academic medicine and clinical and translational science (CTS) may broaden the medical research agenda 3 , allow for more diverse clinical trial recruitment 4 , support institutional excellence 5,6 , and enhance education. 4 As such, diversity, equity, and inclusion (DEI) in CTS are paramount to driving science forward and increasing health equity. ...
... Presently, the quantity and quality of interventional studies addressing upstream social determinants of health in gastroenterology and hepatology are described as "grim." [4] There are many barriers to conducting research in this area: (1) the causal relationship between social determinants of health and liver disease is convoluted and complex, (2) in the short term, intervention leads to "soft" nonclinical outcomes (eg, reduced alcohol intake), (3) interventions are often multimorbidity focused, and (4) potential research participants are predominantly in the community rather than hospital settings-limiting the accessibility of the research population to predominantly hospital-based hepatologists. [3] An important additional contributory factor to this lack of evidence is our collective professional insistence on using clinical research methods to solve what are essentially public health problems. ...
... In this mixed-methods study we identified barriers to follow-up colonoscopy at the patient-level (e.g., declined colonoscopy and fear of colonoscopy), provider-level (e.g., not alerting patients of abnormal FIT results and attributing result to another cause), and system-level (e.g., colonoscopy scheduling challenges and COVID-19 procedures) for which there are practical solutions. For example, addressing logistical barriers to colonoscopy including transportation assistance at the patient-level (Bell-Brown et al., 2022), education about abnormal FIT follow-up in patients with a recent colonoscopy at the provider-level, and population health management tools that streamline FIT-based CRC screening at the health system-level, could lead to improvements in follow-up colonoscopy in safety-net systems. Determining which combination of interventions will most effectively improve colonoscopy completion after an abnormal FIT result and testing these interventions is an important next step. ...
... Following their training, many IMGs join the U.S. workforce through private practice, academia, the federal government, or a research facility [2,4,5]. Currently, 25% of the U.S. physician workforce are IMGs [6]. It has been predicted that by 2020-2025, there will be a shortage of 200,000 physicians in the U.S., resulting in a 20% gap in required healthcare coverage [7] that could potentially be filled by IMGs. ...
... These results contrast with the finding from prior research that higher household wealth increases utilization of preventive services such as CRC screening (Morales et al., 2004;Solmi et al., 2015). However, our findings do align with published studies suggesting that money is not a key determinant of having completed a CRC screening exam (Issaka & Dominitz, 2021;Levin, 2017). For example, offering a financial incentive to adults who are eligible for CRC screening has not been consistently found to increase screening uptake (Facciorusso et al., 2021), although larger incentives (e.g., $100) that offset some of the costs associated with screening may help to some degree compared with smaller incentives (e.g., $5, $10; Mehta et al., 2017). ...
... For our qualitative analysis, we applied a hybrid approach combining inductive and deductive methods (Hsieh and Shannon, 2005). We have described our process in detail elsewhere (Issaka et al., 2021), but in brief, two authors (RBI & ABB), developed an initial list of codes and definitions in a deductive fashion informed by the social cognitive theory. Then in an inductive approach, the coders independently reviewed a subset of the same interviews, created additional subcodes to reflect participants' responses, and compared common themes and relevant quotes to ensure intercoder reliability. ...
... At present, there is a lack of representation of female physicians in senior and leadership roles in gastroenterology that can only be addressed by support and promotion of current female faculty. Though cultural change will take time, active steps can be taken now to improve visibility of female physicians through their inclusion as speakers at conferences, on panels, editorial boards, authorship lists, and in leadership positions [4][5][6][7]. If young female trainees are aware of more female physicians' successes, they may retain faith that they, too, have a path to successful career in gastroenterology. ...
... They reported no statistically significant differences in endoscopy completion by sociodemographic factors but reported significant delays in procedure for screening purposes. 12 Therefore, as we move forward with new COVID-19 surges and variants, it is important to mobilize efforts, especially in vulnerable populations to reduce follow-up loss. ...